Get startedLog in
    Picture of Sensorion SA logo

    ALSEN — Sensorion SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Sensorion Submits Clinical UK Trial Application For Lead Gene Therapy Candidate Otof-Gt

    Picture of Sensorion SA logoSensorion SA
    10/07/2023 06:35
    July 10 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION SUBMITS CLINICAL TRIAL APPLICATION FOR LEAD GENE
THERAPY CANDIDATE OTOF-GT IN THE UK
    * PHASE 1/2 CLINICAL TRIAL (AUDIOGENE), AIMS TO EVALUATE
SAFETY,
TOLERABILITY AND EFFICACY OF INTRA-COCHLEAR INJECTION OF OTOF-GT
    * SENSORION PLANS TO SUBMIT CTA IN EUROPE IN COMING WEEKS

Source text for Eikon:  ID:nBw1ZLNgya 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))

    Recent news on Sensorion SA

    See all news